Advanced Biological Laboratories has signed a commercial licensing agreement with the Public Research Center for Health (CRP-Santé), a Luxembourg-based biomedical research organization that allows it to include the latter's Context-based Modeling for Expeditious Typing (COMET) software, a tool for analyzing and classifying viral sequences, in its portfolio.
Chalom Sayada, CEO of ABL — which is also based in Luxembourg — said that his firm has already incorporated the software into DeepChek, its software for analyzing genomic data from HIV, hepatitis B virus, and HCV. "We are pleased …to have signed this exclusive commercial licensing agreement with CRP-Santé and to be able to promote COMET alone or embedded within ABL’s software applications," he said in a statement.
The financial terms of the agreement were not disclosed. COMET is still freely available for non-commercial research use.